Search results
Novartis (NVS) Q2 Earnings & Revenues Top, Guidance Raised
Zacks via Yahoo Finance· 10 months agoSwiss pharma giant Novartis AG NVS reported strong second-quarter 2023 results and shares are...
Novartis (NVS) Tops Q3 Earnings, Ups Operating Income View
Zacks via Yahoo Finance· 7 months agoSwiss pharma giant Novartis AG NVS reported strong sales from key drugs in third-quarter 2023 and...
Novartis (NVS) Oncology Drug Gets FDA Nod for Label Expansion
Zacks via Yahoo Finance· 1 year agoNovartis NVS announced that the FDA granted approval to the combination of Tafinlar (dabrafenib) and...
Novartis (NVS) Entresto Patent Faces Setback, Stock Down
Zacks via Yahoo Finance· 10 months agoNovartis NVS recently received an unfavorable ruling from the U.S. District Court for the District...
Novartis (NVS) Q2 2022 Earnings Call Transcript
Motley Fool· 2 years agoImage source: The Motley Fool. Novartis (NYSE: NVS) Q2 2022 Earnings Call Jul 19, 2022, 8:00 a.m. ET Contents: Prepared Remarks Questions and Answers...
Novartis (NVS) Wins FDA Nod for Label Expansion of Kymriah
Zacks via Yahoo Finance· 2 years agoNovartis NVS announced that the FDA has approved a label expansion of its CAR-T cell therapy Kymriah...
Novartis (NVS) Gets CHMP Positive Opinion for Entresto Approval
Zacks via Yahoo Finance· 1 year agoNovartis NVS announced that its cardiovascular drug Entresto (sacubitril/valsartan) has received a...
Pharma Stock Roundup: NVS, MRK Report Q3 Earnings JNJ's Tecvayli Gets FDA Nod
Zacks via Yahoo Finance· 2 years agoThis week, Novartis NVS and Merck MRK announced their third-quarter earnings. The FDA approved J&J’s...
2 Biotech Stocks That Could Make You Richer
Motley Fool· 1 year agoGrowing one's wealth in the stock market is simple, at least in theory. All that's needed are time, the right investments, and the patience to hold...
Pharma Stock Roundup: SNY, MRK, NVS Report Q3 Earnings, FDA Okays PFE, LLY Products
Zacks via Yahoo Finance· 7 months agoThis week, Merck MRK, Sanofi SNY and Novartis NVS announced their third-quarter results. The FDA...